Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium Gel 3% vs Solaraze in Actinic Keratosis
NCT02611804Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Oct 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diclofenac in actinic keratosis (AK), sponsored by Teva Pharmaceutical Industries Ltd.. Started Oct 2015; status: completed.
02
Drugs
diclofenac
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02611804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02611804.